Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto que contiene fluocinolona en forma farmacéutica para administración cutánea como único ingrediente (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | producto con fluocinolona | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | Fluocinolone acetonide topical preparation (product) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | tiene ingrediente activo (atributo) | Fluocinolone acetonide (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | tiene ingrediente activo (atributo) | hormona suprarrenal | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | tiene ingrediente activo (atributo) | corticosterona | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | tiene ingrediente activo (atributo) | Adrenal hormone agent (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | es un[a] | Product containing fluocinolone in topical dosage form (medicinal product form) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | ungüento cutáneo (forma farmacéutica) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value (attribute) | 62,5 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Count of base of active ingredient | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | tiene base de sustancia de la potencia | Fluocinolone acetonide (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Fluocinolone acetonide (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets